|
Can't attend? Don't worry, this webinar will be recorded and made available to all those who have registered to view on demand. |
Kind regards, |
ASX Events |
Speakers |
|
Ioneer Limited (ASX:INR) Bernard Rowe, Managing Director Read more > |
Ioneer Limited (ASX:INR) is the 100% owner of the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA, the only known lithium-boron deposit in North America and one of only two known such deposits in the world. The Definitive Feasibility Study (DFS) completed in 2020 confirmed Rhyolite Ridge as a world-class lithium and boron project that is expected to become a globally significant, long-life, low-cost source of lithium and boron vital to a sustainable future. In September 2021, Ioneer entered a 50/50 joint venture agreement with Sibanye-Stillwater to advance the Rhyolite Ridge project and signed a separate offtake agreement with Ford Motor Company and PPES (joint venture between Toyota and Panasonic) in 2022 and Korea’s EcoPro Innovation in 2021. Ioneer will be the operator of the Project.
|
|
| |
Imugene Limited (ASX:IMU) Leslie Chong, Managing Director & CEO Read more > |
Imugene Limited (ASX:IMU) is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumours. Imugene’s product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies such as CAR T’s for solid tumours. Imugene is supported by a leading team of international cancer experts with a vision to help transform and improve the treatment of cancer, backed by a growing body of clinical evidence and peer-reviewed research. Imugene is well funded and resourced to deliver on its commercial and clinical milestones, with a goal of ensuring that the company and its shareholders are at the forefront of this rapidly growing global market.
|
|
| |
Siteminder Limited (ASX:SDR) Sankar Narayan, Chief Executive Officer & Managing Director Read more > |
SiteMinder Limited (ASX:SDR) is the world’s leading open hotel commerce platform, empowering hotels and accommodation providers to sell, market, manage and grow their business. SiteMinder’s innovative online platform offers hotels and accommodation providers a comprehensive range of products and solutions to manage and streamline the distribution of their rooms across a wide selection of direct and indirect channels, take bookings from guests and communicate with guests. The global company, headquartered in Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generates more than 100 million reservations worth over US$35 billion in revenue for hotels each year.
|
|
| |
Vulcan Steel Limited (ASX:VSL) Rhys Jones, Chief Executive Officer & Managing Director Read more > |
Founded in 1995, Vulcan Steel (ASX:VSL) is an Australasian-wide industrial product distributor and value-added processor with 29 logistics and processing facilities employing over 800 staff across the company’s Steel and Metals divisions. Vulcan continuously strives to achieve best-in-class operational excellence in inventory management, processing capabilities, management of overheads and customer service.
|
|
| |
Telix Pharmaceuticals Limited (ASX:TLX) Dr. Christian Behrenbruch, Chief Executive Officer & Managing Director Read more > |
Telix (ASX:TLX) is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, Switzerland and the United States. Telix is developing a portfolio of clinical-stage products that address significant unmet medical need in oncology and rare diseases. Telix’s lead product, gallium-68 (68Ga) gozetotide (also known as 68Ga PSMA-11) injection for prostate cancer imaging, has been approved by the U.S. Food and Drug Administration (FDA), and Australian Therapeutic Goods Administration (TGA), and we are also progressing marketing authorisation applications for this investigational candidate in Europe and Canada.
|
|
| |
Telstra Corporation Limited (ASX:TLS) Michael Ackland, Chief Financial Officer Read more > |
Telstra (ASX:TLS) is Australia’s leading telecommunications and technology company, offering a full range of communications services and competing in all telecommunications markets. We believe it’s people who give purpose to our technology. That's why our purpose is to build a connected future so everyone can thrive. That’s why we build technology and content solutions that are simple and easy to use, including Australia’s largest and fastest national mobile network. And that’s why we strive to serve and know our customers better than anyone else – offering a choice of not just digital connection, but digital content as well.
|
|
| |
Alumina Limited (ASX:AWC) Michael Ferraro, Chief Executive Officer & Managing Director Read more > |
Alumina Limited (ASX:AWC) is a leading Australian resource company with a specific focus on alumina. Alumina’s strategy is to invest world-wide in bauxite mining, alumina refining and selected aluminium smelting operations through our 40% ownership of Alcoa World Alumina & Chemicals (AWAC), one of the world's largest alumina businesses.
|
|
|